Suppr超能文献

牛奥氏盘尾丝虫感染作为人类盘尾丝虫病模型:最新进展

Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments.

作者信息

Trees A J, Graham S P, Renz A, Bianco A E, Tanya V

机构信息

Liverpool School of Tropical Medicine/Faculty of Veterinary Science, University of Liverpool, UK.

出版信息

Parasitology. 2000;120 Suppl:S133-42. doi: 10.1017/s0031182099005788.

Abstract

The bovine parasite Onchocerca ochengi is a nodule-dwelling filarial nematode, closely related to O. volvulus, the causal agent of human River Blindness, and, sharing with it, the same vector. This brief review, based on a presentation at the BSP Autumn Symposium 1999, describes recent work supported by the WHO Drug Development Research Macrofil programme and the Edna McConnell Clark Foundation vaccine development programme, to research the chemotherapy and immunology of onchocerciasis utilising this model system, with experimental infections in Liverpool and field infections in northern Cameroon. In a series of chemotherapeutic trials involving 10 compounds in 20 treatment regimes, the comparability of drug efficacy against O. ochengi with that described against O. volvulus has been demonstrated. Repeated, long-term treatment with oxytetracycline has been shown to be macrofilaricidal and the effect is hypothesized to be related to action on Wolbachia endobacteria, abundant in O. ochengi. Avermectins/milbemycins are not macrofilaricidal (even in high and repeated long-term treatments) but induce sustained abrogation of embryogenesis. In prospective, field exposure experiments with naive calves, prophylactic treatments with ivermectin and moxidectin prevented the development of adult worm infection, raising the possibility that drug-attenuated larval challenge infections may induce immunity. Putatively immune adult cattle exist in endemically exposed populations, and these have been shown to be significantly less susceptible to challenge than age-matched naive controls, whereas radically drug-cured, previously patently-infected cattle were not. Experimental infections with O. ochengi have revealed the kinetics of the immune response in relation to parasite development and demonstrate analogous responses to those reported in O. volvulus infection in humans and chimpanzees. In an immunization experiment with irradiated L3 larvae, cattle were significantly protected against experimental challenge--the first such demonstration of the experimental induction of immunity in a natural Onchocerca host-parasite system. Taken collectively, these studies not only demonstrate the similarity between the host-parasite relationships of O. ochengi in cattle and O. volvulus in humans, but promise to advance options for the control of human onchocerciasis.

摘要

牛寄生虫奥氏盘尾丝虫是一种寄生于结节内的丝虫线虫,与引起人类河盲症的旋盘尾丝虫密切相关,且二者拥有相同的传播媒介。这篇简短综述基于1999年英国寄生虫学会秋季研讨会上的一次报告,描述了由世界卫生组织药物研发研究大型丝虫项目和埃德娜·麦康奈尔·克拉克基金会疫苗研发项目支持的近期研究工作,该研究利用这个模型系统,在利物浦进行实验性感染以及在喀麦隆北部进行现场感染,来研究盘尾丝虫病的化疗和免疫学。在一系列涉及20种治疗方案中的10种化合物的化疗试验中,已证明针对奥氏盘尾丝虫的药物疗效与针对旋盘尾丝虫所描述疗效的可比性。已表明用土霉素进行反复、长期治疗具有杀成虫作用,据推测其作用与对奥氏盘尾丝虫中大量存在的沃尔巴克氏体细菌的作用有关。阿维菌素/米尔倍霉素不具有杀成虫作用(即使在高剂量且反复长期治疗的情况下),但能诱导胚胎发生持续终止。在对未感染小牛进行的前瞻性现场暴露实验中,用伊维菌素和莫昔克丁进行预防性治疗可防止成虫感染的发生,这增加了药物减弱的幼虫激发感染可能诱导免疫的可能性。在地方病流行地区已感染的牛群中存在假定具有免疫力的成年牛,且已表明这些牛比年龄匹配的未感染对照对激发感染的易感性显著更低,而经过彻底药物治愈、先前明显感染过的牛则不然。用奥氏盘尾丝虫进行的实验性感染揭示了免疫反应相对于寄生虫发育的动力学,并证明了与人类和黑猩猩旋盘尾丝虫感染中所报告的类似反应。在一项用经辐照的L3幼虫进行的免疫实验中,牛受到显著保护而免受实验性激发——这是在天然盘尾丝虫宿主 - 寄生虫系统中首次通过实验诱导免疫的此类证明。总体而言,这些研究不仅证明了牛体内奥氏盘尾丝虫与人体内旋盘尾丝虫宿主 - 寄生虫关系之间存在相似性,而且有望推进控制人类盘尾丝虫病的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验